Impaired vibrotactile sense at low frequencies in fingers in autoantibody positive and negative diabetes. Dahlin, E; Ekholm, Ella; Gottsäter, Anders; Speidel, T; Dahlin, Lars 
Neuropathy develops earlier in type 1 [1] than in type 2 diabetic rats [2] , but data in humans are conflicting. Disturbed vibrotactile sense depends on definition and type of subjects as well as upon evaluated extremity [3] [4] [5] [6] . Autoimmune activity [presence of islet antibodies: glutamic acid decarboxylase antibodies (GADA), islet cell antibodies (ICA) and antibodies] in type 1 diabetes predicts beta-cell failure, whereas beta-cell damage is less pronounced in autoantibody negative type 2 diabetes [7] , but its potential long term influence on vibrotactile sense, presently examined in subjects with autoantibody positive and negative diabetes, is unknown.
Materials and methods
Consecutive adult subjects with diabetes diagnosed 1985-1987 (age >15 years; n=233) were followed up. After 20 years 50/118 survivors [7] were examined with respect to vibrotactile sense, length, weight, blood pressure, blood samples, type of diabetes treatment and complications. Subjects were regarded as islet autoantibody positive if they had one or more types of antibodies (GADA, IA-2A and ICA) at onset. Vibrotactile thresholds in index and little finger pulps, reflecting median and ulnar nerve function, respectively, at different frequencies (8, 16, 32, 64, 125, 250 and 500 Hz) were measured by tactilometer [3, 4] . 
Results
All presented comparisons of autoantibody positive (n=15) and autoantibody negative (n=35) diabetic patients were done 20 years after diagnosis of diabetes if not otherwise stated (Table   1) . HbA1c values decreased during follow up (onset, 3, 5 and 20 years after diagnosis) in autoantibody positive (p=0.026), but not in autoantibody negative patients (Fig. 1) .
Two different control groups [3, 4] were included since thresholds increase with age.
Essentially no differences between subjects with autoantibody positive and negative diabetes were detected. Subjects with autoantibody positive and negative diabetes showed significantly higher vibration thresholds, mainly at lower frequencies (8 and 16 Hz), in the index and little fingers bilaterally. Vibration thresholds were significantly increased in single finger pulps, particularly in subjects with autoantibody positive diabetes (for example 32, 64, 250 and 500 Hz), compared to age-matched control subjects.
A lower sensibility index in both index and little fingers bilaterally was observed in patients with autoantibody positive diabetes compared to age-matched controls. No differences in sensibility index were observed between patients with autoantibody positive and negative diabetes or between patients with autoantibody negative diabetes and their age-matched controls.
The proportion of patients with pathological sensibility index (i.e. <0.8) in at least one or four fingers was not significantly different between autoantibody negative and positive diabetes.
Neither did prevalence of pathological sensibility index among diabetic patients differ from prevalence among healthy controls.
Vibration thresholds did not differ between subjects with HbA1c values > or < 63 mmol/mol 
Discussion
The findings that vibrotactile sense was disturbed particularly at low (8 and 16 Hz) frequencies indicate that mainly Meissner´s corpuscles, and/or their innervating axons, are affected in both autoantibody positive and negative diabetes, while the Pacinian corpuscles, responsible for vibrotactile sense approximately at 80 Hz and higher, or their innervating axons, were less affected [3, 9] . The two groups of subjects had similar duration of diabetes. It would have been valuable to have data on vibrotactile sense at diagnosis, but the present technique was not developed at that time.
As beta-cell function is dependent on the presence of autoantibodies [10], a division of our patients based upon autoimmune activity seems to be more relevant than a division based upon clinical characteristics only, when pathophysiological mechanisms are considered.
Presence of ICA autoantibodies at diagnosis of clinical type 2 diabetes is a marker of a more favorable cardiovascular risk profile five years after diagnosis [11] . There is an association between carotid atherosclerosis and cardiovascular autonomic neuropathy in type 2 diabetes
[12]. However, the relevance of autoantibodies for complications in type 1 diabetes is different. In subjects with type 1 diabetes, high levels of GAD65 antibodies are related to increased severity of complications (retinopathy and nephropathy). Presence of such antibodies is suggested as predictors for progression of type 1 diabetes or complications [13] .
Presence of autoantibodies against GADA at onset of type 1 diabetes also increases the risk for development of diabetic retinopathy [14] , and recently reported anti-endothelial and antineuronal effects of autoantibodies from subjects with diabetes with particularly painful neuropathy [15] are also relevant for our findings. These relationships between autoantibodies and complications (microangiopathy and neuropathy) in type 1 diabetes render our present division in autoantibody positive and negative diabetes appropriate. However, as neuropathy is present also in autoantibody negative diabetes, other pathophysiological mechanisms must also be involved.
The higher proportion of signs of neuropathy in our older control subjects may partly depend on their higher age. In spite of our autoantibody negative patients being significantly older than autoantibody positive patients, few or no differences were found between the groups. A substantial proportion of those with good glycaemic control [HbA1c < 63 mmol/mol (7. 
